Zinda Michael

EVP, CHIEF SCIENTIFIC OFFICER at Repare Therapeutics Inc.

Sold, on record
$6.7M
Dollars the filings state
Form 4 sales
13
Latest Mar 12, 2025
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Repare Therapeutics Inc.Plan not stated
    Mar 15 2022

    Sold 533 shares at $11.30 ($6k)

    Zinda Michael, EVP, Chief Science Officer

    Sold 1.1% of holdings ($526k position)46,041 shares left0x usual sizeFiling

  2. 2 Form 144 notice Repare Therapeutics Inc.Notice
    Jun 6 +448 days

    Filed to sell 10,473 shares ($123k)

    Zinda Michael, Officer

    10b5-1 plan0.7x usual sizeFiling

  3. 3 Form 4 sale Repare Therapeutics Inc.Routine
    Jun 6 same day

    Sold 1,200 shares at $12.04 ($14k)

    Zinda Michael, EVP, Chief Scientific Officer

    10b5-1 planSold 1.7% of holdings ($850k position)69,391 shares left0.1x usual sizeFollows a Form 144Filing

  4. 4 Form 4 sale Repare Therapeutics Inc.Routine
    Jun 7 +1 day

    Sold 6,404 shares at $12.03 ($77k)

    Zinda Michael, EVP, Chief Scientific Officer

    10b5-1 planSold 9.2% of holdings ($835k position)62,987 shares left0.8x usual sizeFollows a Form 144Filing

  5. 5 Form 144 notice Repare Therapeutics Inc.Notice
    Mar 25 +292 days

    Filed to sell 2,210 shares ($11k)

    Zinda Michael, Officer

    10b5-1 planFiling

  6. 6 Form 4 sale Repare Therapeutics Inc.Routine
    Mar 27 +2 days

    Sold 1,350 shares at $4.67 ($6k)

    Zinda Michael, EVP, CHIEF SCIENTIFIC OFFICER

    10b5-1 planSold 1.8% of holdings ($346k position)72,768 shares leftFollows a Form 144Filing

  7. 7 Form 4 sale Repare Therapeutics Inc.Routine
    Apr 1 +5 days

    Sold 860 shares at $4.65 ($4k)

    Zinda Michael, EVP, CHIEF SCIENTIFIC OFFICER

    10b5-1 planSold 1.2% of holdings ($338k position)71,908 shares left0.6x usual sizeFollows a Form 144Filing

  8. 8 Form 4 sale Repare Therapeutics Inc.Unusual
    Mar 12 +345 days

    Sold 5,611 shares at $1.14 ($6k)

    Zinda Michael, EVP, CHIEF SCIENTIFIC OFFICER

    No 10b5-1 planSold 6.5% of holdings ($98k position)80,297 shares left4.4x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (15)

Form 144 notices and Form 4 sales by Zinda Michael
Source
Mar 12, 2025Repare Therapeutics Inc.EVP, CHIEF SCIENTIFIC OFFICERForm 4 sale5,611$6k6.5%UnusualSEC
Apr 1, 2024Repare Therapeutics Inc.EVP, CHIEF SCIENTIFIC OFFICERForm 4 sale860$4k1.2%RoutineSEC
Mar 27, 2024Repare Therapeutics Inc.EVP, CHIEF SCIENTIFIC OFFICERForm 4 sale1,350$6k1.8%RoutineSEC
Mar 25, 2024Repare Therapeutics Inc.OfficerForm 144 notice2,210$11kNoticeSEC
Jun 7, 2023Repare Therapeutics Inc.EVP, Chief Scientific OfficerForm 4 sale6,404$77k9.2%RoutineSEC
Jun 6, 2023Repare Therapeutics Inc.EVP, Chief Scientific OfficerForm 4 sale1,200$14k1.7%RoutineSEC
Jun 6, 2023Repare Therapeutics Inc.OfficerForm 144 notice10,473$123kNoticeSEC
Mar 15, 2022Repare Therapeutics Inc.EVP, Chief Science OfficerForm 4 sale533$6k1.1%Plan not statedSEC
Nov 15, 2021Repare Therapeutics Inc.EVP, Chief Science OfficerForm 4 sale20,000$547k97.4%UnusualSEC
Aug 16, 2021Repare Therapeutics Inc.EVP, Chief Science OfficerForm 4 sale15,000$510k42.2%UnusualSEC
May 17, 2021Repare Therapeutics Inc.EVP, Chief Science OfficerForm 4 sale15,000$491k29.7%UnusualSEC
Dec 29, 2020Repare Therapeutics Inc.EVP, Chief Science OfficerForm 4 sale34,744$1.2M40.7%UnusualSEC
Dec 24, 2020Repare Therapeutics Inc.EVP, Chief Science OfficerForm 4 sale57,979$1.9M40.5%UnusualSEC
Dec 21, 2020Repare Therapeutics Inc.EVP, Chief Science OfficerForm 4 sale40,000$1.3M31.9%UnusualSEC
Dec 18, 2020Repare Therapeutics Inc.EVP, Chief Science OfficerForm 4 sale17,277$604k16.9%Plan not statedSEC